Europe Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030
Description
Europe Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030
Europe transfection reagent and equipment market is projected to register a substantial CAGR of 8.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Europe Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, and Rest of Europe) Industry Trends and Forecast to 2030
Some of the drivers that boost transfection reagents and equipment market’s growth are as follows:
• Rise in the prevalence of chronic diseases
• Utilization of biopharmaceuticals for protein production
Market Players:
Some of the major players operating in the Europe transfection reagents and equipment market are:
• Mirus Bio LLC.
• Promega Corporation
• Polyplus Transfection
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Lonza
• MaxCyte, Inc.
• PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
• Cytiva
• R&D Systems, Inc.
• Takara Bio Inc.
• OriGene Technologies, Inc.
• Beckman Coulter, Inc. (A Subsidiary of Danaher)
• SignaGen Laboratories
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Europe transfection reagent and equipment market is projected to register a substantial CAGR of 8.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Europe Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, and Rest of Europe) Industry Trends and Forecast to 2030
Some of the drivers that boost transfection reagents and equipment market’s growth are as follows:
• Rise in the prevalence of chronic diseases
• Utilization of biopharmaceuticals for protein production
Market Players:
Some of the major players operating in the Europe transfection reagents and equipment market are:
• Mirus Bio LLC.
• Promega Corporation
• Polyplus Transfection
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Lonza
• MaxCyte, Inc.
• PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
• Cytiva
• R&D Systems, Inc.
• Takara Bio Inc.
• OriGene Technologies, Inc.
• Beckman Coulter, Inc. (A Subsidiary of Danaher)
• SignaGen Laboratories
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
188 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Europe Transfection Reagents And Equipment Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Transient Transfection Of Transfection Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market Application Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel
- 4.2 Porter's Five Forces Model
- 5 Industry Insights:
- 6 Europe Transfection Reagents And Equipment Market, Regulations
- 6.1 European Union Regulatory Scenario
- 6.2 U.S. Regulatory Scenario
- 6.3 Japan Regulatory Scenario
- 6.4 China Regulatory Scenario
- 7 Market Overview
- 7.1 Drivers
- 7.1.1 Rise In The Prevalence Of Chronic Diseases
- 7.1.2 Development Of Synthetic Biology Products
- 7.1.3 Growing Demand For Chimeric Genes
- 7.1.4 Large-scale Transfections Used In Clinical Research
- 7.1.5 Utilization Of Biopharmaceuticals In The Production Of Proteins
- 7.2 Restraints
- 7.2.1 High Cost Of Transfection Products
- 7.2.2 Selective Effectiveness Of Transfection Reagents
- 7.2.3 Cell Damage Induced By Transfection Procedure
- 7.3 Opportunities
- 7.3.1 Exploration Of Emerging Market
- 7.3.2 Strategic Initiatives By Market Players
- 7.3.3 Surging Level Of Investment
- 7.4 Challenges
- 7.4.1 Long Approval Procedure
- 7.4.2 Lack Of Safety Level Lab For Virus-associated Transfection
- 7.4.3 Lack Of Trained Professionals
- 8 Europe Transfection Reagent And Equipment Market, By Products
- 8.1 Overview
- 8.2 Reagents & Kits
- 8.3 Instruments
- 9 Europe Transfection Reagent And Equipment Market, By Stage
- 9.1 Overview
- 9.2 Research
- 9.3 Preclinical
- 9.4 Clinical Phases
- 9.5 Commercial
- 10 Europe Transfection Reagent And Equipment Market, By Type
- 10.1 Overview
- 10.2 Transient Transfection Reagents And Equipment
- 10.3 Stable Transection Reagents And Equipment
- 11 Europe Transfection Reagent And Equipment Market, By Methods
- 11.1 Overview
- 11.2 Non-viral Methods
- 11.3 Viral Methods
- 12 Europe Transfection Reagent And Equipment Market, By Types Of Molecule
- 12.1 Overview
- 12.2 Plasmid Dna
- 12.3 Small Interfering Rna (Sirna)
- 12.4 Proteins
- 12.5 Dna Oligonucleotides
- 12.6 Ribonucleoprotein Complexes (Rnps)
- 12.7 Others
- 13 Europe Transfection Reagent And Equipment Market, By Organism
- 13.1 Overview
- 13.2 Mammalian Cells
- 13.3 Plants
- 13.4 Fungi
- 13.5 Virus
- 13.6 Bacteria
- 14 Europe Transfection Reagent And Equipment Market, By Application
- 14.1 Overview
- 14.2 In Vitro Application
- 14.2.1 In Vivo Application
- 14.2.2 Bioproduction
- 14.2.3 Others
- 14.2.4 Synthetic Biology
- 14.2.5 Agriculture
- 14.2.6 Others
- 15 Europe Transfection Reagent And Equipment Market, By End User
- 15.1 Overview
- 15.2 Biopharma
- 15.3 Cros
- 15.4 Cmos/Cdmos
- 15.5 Academia
- 15.6 Hospitals
- 15.7 Clinical Labs
- 15.8 Others
- 16 Europe Transfection Reagent And Equipment Market, By Distribution Channel
- 16.1 Overview
- 16.2 Direct Tender
- 16.3 Retail Sales
- 16.4 Others
- 17 Europe Transfection Reagent And Equipment Market, By Region
- 17.1 Europe
- 17.1.1 Germany
- 17.1.2 U.K.
- 17.1.3 France
- 17.1.4 Italy
- 17.1.5 Russia
- 17.1.6 Spain
- 17.1.7 Turkey
- 17.1.8 Netherlands
- 17.1.9 Belgium
- 17.1.10 Switzerland
- 17.1.11 Rest Of Europe
- 18 Europe Transfection Reagents And Equipment Market, Company Landscape
- 18.1 Company Share Analysis: Europe
- 19 Swot Analysis
- 20 Company Profile
- 20.1 Thermo Fisher Scientific Inc.
- 20.1.1 Company Snapshot
- 20.1.2 Revenue Analysis
- 20.1.3 Company Share Analysis
- 20.1.4 Product Portfolio
- 20.1.5 Recent Development
- 20.2 Roche Molecular Systems, Inc. (A Subsidiary Of F. Hoffmann-la Roche Ltd)
- 20.2.1 Company Snapshot
- 20.2.2 Revenue Analysis
- 20.2.3 Company Share Analysis
- 20.2.4 Product Portfolio
- 20.2.5 Recent Development
- 20.3 Promega Corporation
- 20.3.1 Company Snapshot
- 20.3.2 Company Share Analysis
- 20.3.3 Product Portfolio
- 20.3.4 Recent Development
- 20.4 Takara Bio Inc.
- 20.4.1 Company Snapshot
- 20.4.2 Revenue Analysis
- 20.4.3 Company Share Analysis
- 20.4.4 Product Portfolio
- 20.4.5 Recent Development
- 20.5 Bio-rad Laboratories, Inc.
- 20.5.1 Company Snapshot
- 20.5.2 Revenue Ananlysis
- 20.5.3 Company Share Analysis
- 20.5.4 Product Portfolio
- 20.5.5 Recent Development
- 20.6 Altogen Biosystems
- 20.6.1 Company Snapshot
- 20.6.2 Product Portfolio
- 20.6.3 Recent Development
- 20.7 Applied Biological Materials Inc. (Abm)
- 20.7.1 Company Snapshot
- 20.7.2 Product Portfolio
- 20.7.3 Recent Development
- 20.8 Avanti Polar Lipids (A Subsidiary Of Croda International Plc)
- 20.8.1 Company Snapshot
- 20.8.2 Revenue Analysis
- 20.8.3 Product Portfolio
- 20.8.4 Recent Development
- 20.9 Beckman Coulter, Inc. (A Subsidiary Of Danaher)
- 20.9.1 Company Snapshot
- 20.9.2 Product Portfolio
- 20.9.3 Recent Development
- 20.10 Cytiva
- 20.10.1 Company Snapshot
- 20.10.2 Product Portfolio
- 20.10.3 Recent Development
- 20.11 Fujifilm Irvine Scientific (A Subsidiary Of Fujifilm Holdings Corporation)
- 20.11.1 Company Snapshot
- 20.11.2 Revenue Ananlysis
- 20.11.3 Product Portfolio
- 20.11.4 Recent Development
- 20.12 Genlantis Inc.
- 20.12.1 Company Snapshot
- 20.12.2 Product Portfolio
- 20.12.3 Recent Development
- 20.13 Geno Technology Inc., Usa
- 20.13.1 Company Snapshot
- 20.13.2 Product Portfolio
- 20.13.3 Recent Development
- 20.14 Ginkgo Bioworks
- 20.14.1 Company Snapshot
- 20.14.2 Product Portfolio
- 20.14.3 Recent Developments
- 20.15 Lonza
- 20.15.1 Company Snapshot
- 20.15.2 Revenue Ananlysis
- 20.15.3 Product Portfolio
- 20.15.4 Recent Development
- 20.16 Maxcyte, Inc.
- 20.16.1 Company Snapshot
- 20.16.2 Revenue Analysis
- 20.16.3 Product Portfolio
- 20.16.4 Recent Development
- 20.17 Merck Kgaa
- 20.17.1 Company Snapshot
- 20.17.2 Revenue Analysis
- 20.17.3 Product Portfolio
- 20.17.4 Recent Development
- 20.18 Mirus Bio Llc.
- 20.18.1 Company Snapshot
- 20.18.2 Product Portfolio
- 20.18.3 Recent Development
- 20.19 Origene Technologies, Inc.
- 20.19.1 Company Snapshot
- 20.19.2 Product Portfolio
- 20.19.3 Recent Development
- 20.20 Perkinelmer Chemagen Technologie Gmbh (A Subsidiary Of Perkinelmer Inc.)
- 20.20.1 Company Snapshot
- 20.20.2 Revenue Analysis
- 20.20.3 Product Portfolio
- 20.20.4 Recent Development
- 20.21 Polyplus Transfection
- 20.21.1 Company Snapshot
- 20.21.2 Product Portfolio
- 20.21.3 Recent Development
- 20.22 R&D Systems, Inc.
- 20.22.1 Company Snapshot
- 20.22.2 Product Portfolio
- 20.22.3 Recent Development
- 20.23 Sbs Genetech
- 20.23.1 Company Snapshot
- 20.23.2 Product Portfolio
- 20.23.3 Recent Development
- 20.24 Signagen Laboratories
- 20.24.1 Company Snapshot
- 20.24.2 Product Portfolio
- 20.24.3 Recent Development
- 21 Questionnaire
- 22 Related Reports 188
- List Of Tables
- Table 1 Europe Transfection Reagent And Equipment Market, By Products, 2021-2030 (Usd Thousand)
- Table 2 Europe Reagent And Kits In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 3 Europe Instruments In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 4 Europe Transfection Reagent And Equipment Market, By Stage, 2021-2030 (Usd Thousand)
- Table 5 Europe Research In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 6 Europe Preclinical In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 7 Europe Clinical Phases In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 8 Europe Commercial In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 9 Europe Transfection Reagent And Equipment Market, By Type, 2021-2030 (Usd Thousand)
- Table 10 Europe Transient Transfection Reagents And Equipment In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 11 Europe Stable Transfection Reagents And Equipment In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 12 Europe Transfection Reagents And Equipment Market, By Methods, 2021-2030 (Usd Thousand)
- Table 13 Europe Non-viral Methods In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 14 Europe Viral Methods In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 15 Europe Transfection Reagent And Equipment Market, By Types Of Molecule, 2021-2030 (Usd Thousand)
- Table 16 Europe Plasmid Dna In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 17 Europe Small Interfering Rna (Sirna) In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 18 Europe Proteins In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 19 Europe Dna Oligonucleotides In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 20 Europe Ribonucleoprotein Complexes (Rnps) In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 21 Europe Others In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 22 Europe Transfection Reagent And Equipment Market, By Organism, 2021-2030 (Usd Thousand)
- Table 23 Europe Mammalian Cells In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 24 Europe Plants In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 25 Europe Fungi In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 26 Europe Virus In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 27 Europe Bacteria In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 28 Europe Transfection Reagent And Equipment Market , By Application, 2021-2030 (Usd Thousand)
- Table 29 Europe In Vitro Application In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 30 Europe In Vivo Application In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 31 Europe Bioproduction In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 32 Europe Others In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 33 Europe Application In Transfection Reagent And Equipment Market, By Industry, 2021-2030 (Usd Thousand)
- Table 34 Europe Transfection Reagent And Equipment Market, By End User, 2021-2030 (Usd Thousand)
- Table 35 Europe Biopharma In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 36 Europe Cros In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 37 Europe Cmos/Cdmos In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 38 Europe Academia In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 39 Europe Hospitals In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 40 Europe Clinical Labs In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 41 Europe Others In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 42 Europe Transfection Reagent And Equipment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 43 Europe Direct Tender In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 44 Europe Retail Sales In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand)
- Table 45 Europe Others In Transfection Reagent And Equipment Market, By Region, 2021-2030 (Usd Thousand) 130
- List Of Figures
- Figure 1 Europe Transfection Reagents And Equipment Market: Segmentation
- Figure 2 Europe Transfection Reagents And Equipment Market: Data Triangulation
- Figure 3 Europe Transfection Reagents And Equipment Market: Droc Analysis
- Figure 4 Europe Transfection Reagents And Equipment Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Transfection Reagents And Equipment Market: Company Research Analysis
- Figure 6 Europe Transfection Reagents And Equipment Market: Multivariate Modelling
- Figure 7 Europe Transfection Market: Interview Demographics
- Figure 8 Europe Transfection Reagents And Equipment Market: Dbmr Market Position Grid
- Figure 9 Europe Transfection Reagents And Equipment Market: Market Application Coverage Grid
- Figure 10 Europe Transfection Reagents And Equipment Market: Vendor Share Analysis
- Figure 11 Europe Transfection Reagents And Equipment Market: Segmentation
- Figure 12 Increasing Occurence Of Chronic Diseases And Development Of Synthetic Biology Products Is Driving The Europe Transfection Reagents And Equipment Market In The Forecast Period Of 2022 To 2030
- Figure 13 The Transient Transfection Segment Is Expected To Account For The Largest Share Of The Europe Transfection Reagents And Equipment Market In 2022 & 2030
- Figure 14 Approval Process For Gene Therapy In China
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Europe Transfection Reagents And Equipment Market
- Figure 16 Europe Transfection Reagent And Equipment Market: By Products, 2023
- Figure 17 Europe Transfection Reagent And Equipment Market: By Products, 2023-2030 (Usd Thousand)
- Figure 18 Europe Transfection Reagent And Equipment Market: By Products, Cagr (2023-2030)
- Figure 19 Europe Transfection Reagent And Equipment Market: By Products, Lifeline Curve
- Figure 20 Europe Transfection Reagent And Equipment Market: By Stage, 2023
- Figure 21 Europe Transfection Reagent And Equipment Market: By Stage, 2023-2030 (Usd Thousand)
- Figure 22 Europe Transfection Reagent And Equipment Market: By Stage, Cagr (2023-2030)
- Figure 23 Europe Transfection Reagent And Equipment Market: By Stage, Lifeline Curve
- Figure 24 Europe Transfection Reagent And Equipment Market: By Type, 2023
- Figure 25 Europe Transfection Reagent And Equipment Market: By Type, 2023-2030 (Usd Thousand)
- Figure 26 Europe Transfection Reagent And Equipment Market: By Type, Cagr (2023-2030)
- Figure 27 Europe Transfection Reagent And Equipment Market: By Type, Lifeline Curve
- Figure 28 Europe Transfection Reagents And Equipment Market: By Methods, 2022
- Figure 29 Europe Transfection Reagents And Equipment Market: By Methods, 2023-2030 (Usd Thousand)
- Figure 30 Europe Transfection Reagents And Equipment Market: By Methods, Cagr (2023-2030)
- Figure 31 Europe Transfection Reagents And Equipment Market: By Methods, Lifeline Curve
- Figure 32 Europe Transfection Reagent And Equipment Market: By Types Of Molecule, 2022
- Figure 33 Europe Transfection Reagent And Equipment Market: By Types Of Molecule, 2023-2030 (Usd Thousand)
- Figure 34 Europe Transfection Reagent And Equipment Market: By Types Of Molecule, Cagr (2023-2030)
- Figure 35 Europe Transfection Reagent And Equipment Market: By Types Of Molecule, Lifeline Curve
- Figure 36 Europe Transfection Reagent And Equipment Market: By Organism, 2022
- Figure 37 Europe Transfection Reagent And Equipment Market: By Organism, 2023-2030 (Usd Thousand)
- Figure 38 Europe Transfection Reagent And Equipment Market: By Organism, Cagr (2023-2030)
- Figure 39 Europe Transfection Reagent And Equipment Market: By Organism, Lifeline Curve
- Figure 40 Europe Transfection Reagent And Equipment Market By Application, 2022
- Figure 41 Europe Transfection Reagent And Equipment Market By Application, 2023-2030 (Usd Thousand)
- Figure 42 Europe Transfection Reagent And Equipment Market By Application, Cagr (2023-2030)
- Figure 43 Europe Transfection Reagent And Equipment Market By Application, Lifeline Curve
- Figure 44 Europe Transfection Reagent And Equipment Market: By End User, 2022
- Figure 45 Europe Transfection Reagent And Equipment Market : By End User, 2023-2030 (Usd Thousand)
- Figure 46 Europe Transfection Reagent And Equipment Market : By End User, Cagr (2023-2030)
- Figure 47 Europe Transfection Reagent And Equipment Market : By End User, Lifeline Curve
- Figure 48 Europe Transfection Reagent And Equipment Market: By Distribution Channel, 2022
- Figure 49 Europe Transfection Reagent And Equipment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
- Figure 50 Europe Transfection Reagent And Equipment Market: By Distribution Channel, Cagr (2023-2030)
- Figure 51 Europe Transfection Reagent And Equipment Market: By Distribution Channel, Lifeline Curve
- Figure 52 Europe Transfection Reagent And Equipment Market: Snapshot (2022)
- Figure 53 Europe Transfection Reagent And Equipment Market: By Country (2022)
- Figure 54 Europe Transfection Reagent And Equipment Market: By Country (2023 & 2030)
- Figure 55 Europe Transfection Reagent And Equipment Market: By Country (202 & 2030)
- Figure 56 Europe Transfection Reagent And Equipment Market: By Products (2023-2030)
- Figure 57 Europe Transfection Reagents And Equipment Market: Company Share 2022 (%) 137
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
